Effects of Wheat Breads on Symptoms of IBS, a Pilot Study
Wheat-IBS
1 other identifier
interventional
26
1 country
1
Brief Summary
This is randomized pilot study comparing tolerability of yeast-baked wheat bread and sourdough wheat bread in irritable bowel syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 5, 2015
CompletedFirst Posted
Study publicly available on registry
October 9, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedAugust 5, 2016
August 1, 2016
7 months
October 5, 2015
August 4, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Subjective symptoms using visual analog scale (VAS) daily
Self-reports of bloating, dyspepsia, constipation, diarrhoea, abdominal pain, borborygmi, flatulence, heart burn, urgency to defecate, incomplete feeling of defecation, abdominal cramps, tiredness, skin rash, mood, nausea, joint pain, ability to concentrate and loss of appetite on VAS 0-100. Participants fill in VAS questionnaires at the end of each day
7 days
Study Arms (3)
Fermented wheat bread for 7 days
ACTIVE COMPARATORLong sourdough fermentation
Yeast baked wheat bread for 7 days
PLACEBO COMPARATORRegular toast bread
Run-in
OTHERGluten-free diet for 7 days before entering either bread period
Interventions
Gluten-free diet excluding even oats and buckwheat. Rice, quinoa, corn and potato allowed as grains/pseudo-grains
Eligibility Criteria
You may qualify if:
- IBS \& subjective sensitivity to wheat
You may not qualify if:
- celiac disease, pregnancy, lactation, IBD, major GI operations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oy Karl Fazer Ablead
Study Sites (1)
Aava Medical Centre
Helsinki, Helsinki, 00100, Finland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 5, 2015
First Posted
October 9, 2015
Study Start
August 1, 2015
Primary Completion
March 1, 2016
Study Completion
March 1, 2016
Last Updated
August 5, 2016
Record last verified: 2016-08